SEC 13F Intelligence

Carlson Capital, L.P. / ALDR1EUR

Carlson Capital, L.P.’s Alder Biopharmaceuticals Inc Position

Does Carlson Capital, L.P. own Alder Biopharmaceuticals Inc (ALDR1EUR)? Not currently — the last reported position was 3.55M shares worth $67M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$67M
Q3 2019
Shares
3.55M
% of Portfolio
+1.21%
Quarters Held
1
position exited

Position History ALDR1EUR

Reported value by quarter
Q3 ’19: $67MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20193.55M$67M+1.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of ALDR1EUR.